416 SQ3370–001 is a multi-center open-label phase I dose-escalation study to test a novel intratumoral and systemic approach to treat advanced solid tumors by Vivek Subbiah, Ravi Murthy, Alexander Guminski, Ding Wang, Vivek Bhadri, Nam Bui, Jose Mejia Oneto, Kamalesh Sankhala, M Wayne Saville, Sangeetha Srinivasan, Robert Steffner, Nathan Yee